首页|基于"肺虚络瘀"理论及网络药理学与分子对接探析黄芪-丹参药对治疗肺纤维化作用机制

基于"肺虚络瘀"理论及网络药理学与分子对接探析黄芪-丹参药对治疗肺纤维化作用机制

扫码查看
目的 基于"肺虚络瘀"理论及网络药理学与分子对接方法探析中药黄芪-丹参药对配伍治疗肺纤维化的作用机制。方法 借助TCMSP,分别以"黄芪""丹参"为关键词检索药物活性成分及对应靶点,在UniProt蛋白质数据库中将药物成分靶点名称转化为对应基因名;运用OMIM、GeneCards、TTD、DisGeNET等疾病基因数据库,分别检索并筛选肺纤维化疾病的靶点基因。使用venny 2。1在线软件作图工具平台,将药物成分靶点与肺纤维化疾病靶点取交集,获取药物-疾病共同靶点基因,并绘制韦恩图;使用Cytoscape 3。10。0作图软件构建中药-成分-共同靶点-疾病基因网络;再运用String数据库构建其蛋白互作(PPI)网络,同时筛选出核心靶点;运用Metascape数据库对药物-疾病交集靶点进行GO和KEGG富集分析,通过微生信平台对富集结果进行可视化,借助AutoDock 1。5。7软件进行分子对接验证。结果 中药黄芪-丹参药对活性成分共85个,核心成分为槲皮素、山柰酚、丹参酮Ⅵ、丹参酮ⅡA;成分靶点1443个,药物-疾病交集靶点基因共85个,作用于疾病的核心靶点12个;GO富集分析结果分别得到生物过程(BP)1370条,分子功能(MF)91条,细胞组成(CC)60条;KEGG富集分析有169个信号通路;分子对接验证结果显示,小分子配体与蛋白受体之间均有相对稳定的结合力。结论 "黄芪-丹参"药对通过槲皮素、山柰酚、丹参酮ⅡA等多种有效成分,可能通过调控MMP-9、TP-53、TNF、IL-1β、TGF-β1等蛋白表达,从而发挥其抗肺纤维化的作用。
Analyzing Mechanism of Huangqi(Astragali Radix)-Danshen(Salviae Miltiorrhizae Radix et Rhizoma)in Treatment of Pulmonary Fibrosis Based on Theory of"Lung Deficiency and Collateral Stasis"and Network Pharmacology
Objective To analyze the mechanism of action of Huangqi(Astragali Radix)-Danshen(Salviae Miltiorrhizae Radix et Rhizoma)in the treatment of pulmonary fibrosis based on the theoretical network pharmacology and molecular docking method of the theory of"lung deficiency and collateral stasis".Methods With the help of Traditional Chinese Medicine Systems Pharma-cology Database and Analysis Platform(TCMSP),it searched the active ingredients and the corresponding targets with the key-words of"Huangqi(Astragali Radix)"and"Danshen(Salviae Miltiorrhizae Radix et Rhizoma)"respectively,and converted the names of the targets of the drug ingredients into the corresponding gene names in the UniProt Protein Database.OMIM,Gene-Cards,TTD,DisGeNET and other disease gene databases were used to search and screen the target genes of pulmonary fibrosis diseases.Venny 2.1 online software was applied for mapping tool platform.The intersection of drug component targets and pul-monary fibrosis disease targets were taken to obtain drug-disease common target genes and draw the Wayne diagram.Cytoscape 3.10.0 mapping software was used to construct the traditional Chinese medicine-component-common target-disease gene net-work;and String database was used to construct the protein-protein-interaction(PPI)network,and the core targets were screened.At the same time,the core targets were screened out.The Metascape database was used to analyze the GO and KEGG enrichment of drug-disease intersecting targets,and the enrichment results were visualized through the microbiology platform,and molecular docking was verified with the help of AutoDock 1.5.7 software.Results The total number of active ingredients of Huangqi(Astragali Radix)-Danshen(Salviae Miltiorrhizae Radix et Rhizoma)was 85,and the core ingredients were quercetin,kaempferol,tanshinone Ⅵ and tanshinone ⅡA.The number of constituent targets was 1443,and the total number of target genes of drug-disease intersection was 85,and the core targets of disease were 12.The results of GO enrichment analysis yielded 1,370 items of bioprocesses,91 items of molecular functions and 60 items of cellular compositions.The results of KEGG enrichment analysis yielded 1,370 items of biological processes,60 items of CC,and the results of KEGG enrichment were visualized with the help of AutoDock 1.5.7 software.The results of GO enrichment analysis showed 1370 biological processes(BP),91 molecular functions(MF)and 60 cellular components(CC).A total of 169 signaling pathways were analyzed by KEGG enrichment analysis and the results of molecular docking validation showed that there was a relatively stable binding force between the small molecule ligands and protein receptors.Conclusion Huangqi(Astragali Radix)-Danshen(Salviae Miltiorrhizae Radix et Rhizoma)may exert its effects by regulating the protein expressions of MMP-9,TP-53,TNF,IL-1β,TGF-β1 through quercetin,kaempfer-ol,tanshinone ⅡA and other active ingredients,thus exerting its anti-lung fibrosis effect.

Huangqi(Astragali Radix)-Danshen(Salviae Miltiorrhizae Radix et Rhizoma)theory of"lung deficiency and collateral stasis"network pharmacologymolecular dockingpulmonary fibrosis

余琼、于雪峰

展开 >

辽宁中医药大学,辽宁沈阳 110847

辽宁中医药大学附属第二医院,辽宁沈阳 110034

黄芪-丹参 "肺虚络瘀"理论 网络药理学 分子对接 肺纤维化

2024

实用中医内科杂志
辽宁省中医药学会,中华中医药学会,辽宁省中医药研究院

实用中医内科杂志

影响因子:0.421
ISSN:1671-7813
年,卷(期):2024.38(12)